Federal Criminal Police Office, Forensic Science Institute, Wiesbaden, Germany.
Joint Mass Spectrometry Centre, Institute of Chemistry, Chair of Analytical Chemistry, University of Rostock, Rostock, Germany.
Drug Test Anal. 2019 Aug;11(8):1192-1206. doi: 10.1002/dta.2652. Epub 2019 Jun 17.
In this work, the most discriminating synthesis-related impurities found in samples from seizures and controlled synthesis of the synthetic cannabinoid MDMB-CHMICA (methyl (S)-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) were characterized. Based on 61 available powder samples of MDMB-CHMICA, 15 key-impurities were assessed, isolated in larger quantities via flash chromatography and structurally elucidated and characterized via high resolution mass spectrometry and nuclear magnetic resonance spectroscopy. Apart from verifying the relation of the impurities to the major component, the interpretation of their chemical structures with distinct structural elements provided first insights into the manufacturing process and the precursor compounds used. Following liquid chromatography mass spectrometry analysis of the 15 key-impurities, the 61 seized samples of MDMB-CHMICA were evaluated and classified via multivariate data analysis based on the corresponding relative peak areas. In a second part of this work, stability tests and multiple controlled syntheses of MDMB-CHMICA were carried out to better understand variations in impurity signatures and to assess the significance of variations in the impurity patterns of seized samples. The last coupling step of the amino acid with 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid was performed using the coupling agents oxalyl chloride, thionyl chloride, and HATU. Furthermore, the impact of reaction time and temperature on the impurity profile were investigated. Overall, eight new impurities were found in the controlled syntheses and two degradation products of MDMB-CHIMCA were found in the course of the stability tests. Replicates of a synthesis conducted on the same day showed similar impurity signatures; on different days they showed discriminable signatures. The use of different coupling reagents or conditions gave clearly distinguishable impurity signatures.
在这项工作中,对从缉获物和合成大麻素 MDMB-CHMICA((S)-2-(1-(环己基甲基)-1H-吲哚-3-羧酰胺基)-3,3-二甲基丁酯)的受控合成中发现的最具鉴别力的合成相关杂质进行了表征。基于 61 个可用的 MDMB-CHMICA 粉末样品,评估了 15 种关键杂质,通过快速色谱法分离出更多数量的杂质,并通过高分辨率质谱和核磁共振波谱法对其结构进行阐明和表征。除了验证杂质与主要成分的关系外,这些具有独特结构元素的化学结构的解释还首次深入了解了制造过程和所用的前体化合物。对 15 种关键杂质进行液相色谱-质谱分析后,根据相应的相对峰面积,通过多元数据分析对 61 个缉获的 MDMB-CHMICA 样品进行评估和分类。在这项工作的第二部分,进行了 MDMB-CHMICA 的稳定性测试和多次受控合成,以更好地了解杂质特征的变化,并评估缉获样品中杂质模式变化的意义。用缩合剂草酰氯、亚硫酰氯和 HATU 进行氨基酸与 1-(环己基甲基)-1H-吲哚-3-羧酸的最后偶联步骤。此外,还研究了反应时间和温度对杂质谱的影响。总的来说,在受控合成中发现了 8 种新的杂质,在稳定性测试过程中发现了 MDMB-CHIMCA 的两种降解产物。同一天进行的合成的重复样品显示出相似的杂质特征;而在不同的日子里,它们显示出可区分的特征。使用不同的偶联试剂或条件会产生明显可区分的杂质特征。